OVA1 is using five different biomarkers compared to other tests, and is much more sensitive especially for detection of early stage disease.- Kathy Anderson MD, FACOG, JD, ABAARM
OVA1 is great in that it can help to avoid second procedures on patients and second operations which can be associated with higher morbidity.- Jonathan Black MD, MPH
OVA1®plus has added to our armamentarium as physicians by decreasing the false positive rate up to 50%- Howard C. Mandel MD, FACOG
Careers At Aspira Women's Health
At ASPIRA Women's health our mission is to globally transform women's health, starting with ovarian cancer.
We are always looking for talented, driven individuals to join our team of innovators. We are a small company with some very big ideas.
Are you ready to help us inspire change in women's health? Then we want to hear from you!